LFMD

BTIG analyst David Larsen maintained a Buy rating on LifeMD (LFMD - Research Report) yesterday and set a price target of $8.00. The company's shares closed yesterday at $2.58.According to TipRanks, Larsen is an analyst with an average return of -8.4% and a 33.97% success rate. Larsen covers the Technology sector, focusing on stocks such as Omnicell, Health Catalyst, and Sharecare.Currently, the analyst consensus on LifeMD is a Moderate Buy with an average price target of $8.00, a 210.08% upside from current levels. In a report released on August 12, B.Riley Financial also maintained a Buy rating on the stock with a $8.00 price target.
https://www.tipranks.com/news/blurbs/lifemd-lfmd-gets-a-buy-from-btig?utm_source=advfn.com&utm_medium=referral